QUEENSBURY, N.Y.--(BUSINESS WIRE)--AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists and surgeons for the minimally-invasive treatment of cancer and peripheral vascular disease, announced today that it will present at the 8th Annual JMP Securities Research Conference in San Francisco on May 19, 2009, at 11:30 a.m. Pacific Time. Jan Keltjens, President and CEO, and Joseph Gersuk, Executive Vice President and CFO of AngioDynamics, will review the Company’s business strategy and historical financial results.
